Nabrink M, Birgersson L, Colling-Saltin A S, Solum T
Department of Obstetrics and Gynecology, Uddevalla, Sweden.
Contraception. 1990 Sep;42(3):275-83. doi: 10.1016/0010-7824(90)90015-n.
Women with primary dysmenorrhoea not sufficiently helped by triphasic oral contraceptives (OCs) were offered a modern, low-dose monophasic OC containing 30 micrograms of ethinylestradiol and 150 micrograms of desogestrel. The study shows that for these women, the monophasic pill was the better alternative. The fact that 19 of 23 women who continue treatment on the monophasic OC indicates that this type of pill may be chosen as the first alternative for women with primary dysmenorrhoea.
对于服用三相口服避孕药（OCs）后痛经仍未得到充分缓解的女性，提供了一种含30微克炔雌醇和150微克去氧孕烯的现代低剂量单相OC。研究表明，对于这些女性，单相避孕药是更好的选择。23名继续服用单相OC进行治疗的女性中有19名，这一事实表明这种类型的避孕药可被选为原发性痛经女性的首选。
